Literature DB >> 26071555

Visualization of Fra-1/AP-1 activation during LPS-induced inflammatory lung injury using fluorescence optical imaging.

Subbiah Rajasekaran1, Chandramohan R Tamatam1, Haranatha R Potteti1, Venu Raman2, Jae-Woo Lee3, Michael A Matthay3, Dolly Mehta4, Narsa M Reddy5, Sekhar P Reddy1.   

Abstract

Inappropriate lung inflammatory response following oxidant and toxicant exposure can lead to abnormal repair and disease pathogenesis, including fibrosis. Thus early detection of molecular and cellular processes and mediators promoting lung inflammation is necessary to develop better strategies for therapeutic intervention and disease management. Previously, we have shown that transcription factor Fra-1/AP-1 plays key roles in lung inflammatory response, as Fra-1-null mice are less susceptible than wild-type mice to LPS-induced lung injury and mortality. Herein, we developed a transgenic reporter mouse model expressing tdTomato under the control of FRA-1 (human) promoter (referred to as FRA-1(TdTg) mice) to monitor its activation during inflammatory lung injury using fluorescence protein-based optical imaging and molecular analysis in vivo and ex vivo. A higher red fluorescent signal was observed in the lungs of LPS-treated FRA-1(TdTg) mice compared with vehicle controls, and Western blot and qRT-PCR analyses revealed a significant correlation with the FRA-1-tdTomato reporter expression. Immunocolocalization demonstrated expression of FRA-1-tdTomato largely in lung alveolar macrophages and to some extent in epithelial cells. Moreover, we validated these results with a second reporter mouse model that expressed green fluorescent protein upon activation of endogenous Fra-1 promoter. Additionally, we demonstrated increased expression of FRA-1 in alveolar macrophages in human lung instilled with Escherichia coli ex vivo. Collectively, our data obtained from two independent reporter mouse models and from human samples underscore the significance of Fra-1 activation in alveolar macrophages during inflammatory lung injury and may aid in developing strategies to target this transcription factor in lung injury and repair.
Copyright © 2015 the American Physiological Society.

Entities:  

Keywords:  Fra-1; acute lung injury; fluorescence; in vivo imaging; tdTomato

Mesh:

Substances:

Year:  2015        PMID: 26071555      PMCID: PMC4538236          DOI: 10.1152/ajplung.00315.2014

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  34 in total

Review 1.  AP-1: a double-edged sword in tumorigenesis.

Authors:  Robert Eferl; Erwin F Wagner
Journal:  Nat Rev Cancer       Date:  2003-11       Impact factor: 60.716

Review 2.  Innate immunity and pulmonary host defense.

Authors:  P Zhang; W R Summer; G J Bagby; S Nelson
Journal:  Immunol Rev       Date:  2000-02       Impact factor: 12.988

Review 3.  The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination.

Authors:  G R Bernard; A Artigas; K L Brigham; J Carlet; K Falke; L Hudson; M Lamy; J R Legall; A Morris; R Spragg
Journal:  Am J Respir Crit Care Med       Date:  1994-03       Impact factor: 21.405

4.  Differential regulation of cytokine release and leukocyte migration by lipopolysaccharide-stimulated primary human lung alveolar type II epithelial cells and macrophages.

Authors:  Andrew J Thorley; Paul A Ford; Mark A Giembycz; Peter Goldstraw; Alan Young; Teresa D Tetley
Journal:  J Immunol       Date:  2007-01-01       Impact factor: 5.422

5.  Both Erk and p38 kinases are necessary for cytokine gene transcription.

Authors:  A B Carter; M M Monick; G W Hunninghake
Journal:  Am J Respir Cell Mol Biol       Date:  1999-04       Impact factor: 6.914

6.  Multiple cis-elements mediate the transcriptional activation of human fra-1 by 12-O-tetradecanoylphorbol-13-acetate in bronchial epithelial cells.

Authors:  Pavan Adiseshaiah; Srinivas R Papaiahgari; Hue Vuong; Dhananjaya V Kalvakolanu; Sekhar P Reddy
Journal:  J Biol Chem       Date:  2003-09-17       Impact factor: 5.157

7.  The Fos-related antigen Fra-1 is an activator of bone matrix formation.

Authors:  Robert Eferl; Astrid Hoebertz; Arndt F Schilling; Martina Rath; Florian Karreth; Lukas Kenner; Michael Amling; Erwin F Wagner
Journal:  EMBO J       Date:  2004-07-01       Impact factor: 11.598

8.  An imageable highly metastatic orthotopic red fluorescent protein model of pancreatic cancer.

Authors:  Matthew H Katz; Shinako Takimoto; Daniel Spivack; A R Moossa; Robert M Hoffman; Michael Bouvet
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

9.  Transcriptional activation of the fra-1 gene by AP-1 is mediated by regulatory sequences in the first intron.

Authors:  G Bergers; P Graninger; S Braselmann; C Wrighton; M Busslinger
Journal:  Mol Cell Biol       Date:  1995-07       Impact factor: 4.272

10.  Fra-1/AP-1 transcription factor negatively regulates pulmonary fibrosis in vivo.

Authors:  Subbiah Rajasekaran; Michelle Vaz; Sekhar P Reddy
Journal:  PLoS One       Date:  2012-07-24       Impact factor: 3.240

View more
  3 in total

1.  Transcription factor Fra-1 targets arginase-1 to enhance macrophage-mediated inflammation in arthritis.

Authors:  Nicole Hannemann; Shan Cao; Daniel Eriksson; Anne Schnelzer; Jutta Jordan; Martin Eberhardt; Ulrike Schleicher; Jürgen Rech; Andreas Ramming; Steffen Uebe; Arif Ekici; Juan D Cañete; Xiaoxiang Chen; Tobias Bäuerle; Julio Vera; Christian Bogdan; Georg Schett; Aline Bozec
Journal:  J Clin Invest       Date:  2019-04-16       Impact factor: 14.808

2.  c-Jun Is Required for Nuclear Factor-κB-Dependent, LPS-Stimulated Fos-Related Antigen-1 Transcription in Alveolar Macrophages.

Authors:  Rakesh K Mishra; Haranatha R Potteti; Chandramohan R Tamatam; Indira Elangovan; Sekhar P Reddy
Journal:  Am J Respir Cell Mol Biol       Date:  2016-11       Impact factor: 6.914

Review 3.  The Fra-1: Novel role in regulating extensive immune cell states and affecting inflammatory diseases.

Authors:  Yu-Yao He; Hai-Feng Zhou; Lu Chen; Yan-Ting Wang; Wan-Li Xie; Zhen-Zhen Xu; Yue Xiong; Yi-Qi Feng; Guo-Yang Liu; Xia Li; Jie Liu; Qing-Ping Wu
Journal:  Front Immunol       Date:  2022-08-11       Impact factor: 8.786

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.